Evaluation of Ventilation Homogeneity as a Marker of Small Airway Disease in Active Smokers

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

January 30, 2019

Primary Completion Date

November 9, 2022

Study Completion Date

November 9, 2022

Conditions
Lung Function TestingCigarette SmokingSingle-photon Emission Computed Tomography (SPECT)Ventilation HomogeneityLung Disease Prevention
Interventions
DIAGNOSTIC_TEST

SPECT/CT

"Technegas-Tc99m is approved by Health Canada for the evaluation of ventilation. Technegas will be prepared with a Technegas Generator (Cyclomedica) according to the manufacturer recommendations with a simmer phase and a burning phase. 95% ethanol will be used to wet the carbon crucible. The crucible will be loaded with 20-30 mCi of Tc99m. Tc99m has a physical half-life of 6 hours.~Technegas will be administered to the patient within 10 minutes of its preparation, in a separate room than the scanning room. The inhalation technique will be rehearsed with the patient prior to the actual inhalation. The patient will be in supine position. A mouth piece and a nose clip will be used. The patient will be instructed to take 3 breaths of Technegas, starting after normal exhalation. A survey meter will be used to monitor the quality of the inhalation."

Trial Locations (1)

H2X 3E4

Centre Hospitalier de l'Université de Montréal (CHUM), Montreal

All Listed Sponsors
collaborator

Cyclomedica Australia PTY Limited

INDUSTRY

lead

Centre hospitalier de l'Université de Montréal (CHUM)

OTHER

NCT03728712 - Evaluation of Ventilation Homogeneity as a Marker of Small Airway Disease in Active Smokers | Biotech Hunter | Biotech Hunter